U.S. market Closed. Opens in 34 minutes

UPC | Universe Pharmaceuticals INC Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-30
Revenue32.31M40.14M47.98M30.70M33.23M28.51M
Cost of Revenue21.99M18.25M22.66M16.61M19.82M15.11M
Gross Profit10.32M21.89M25.33M14.09M13.41M13.41M
Operating Expenses14.28M28.91M11.74M3.74M3.36M3.65M
Selling, General & Admin9.00M20.84M6.27M2.80M2.29M2.39M
Research & Development4.86M7.64M5.47M583.12K618.44K789.38K
Other Operating Expenses-235.61K430.31K-80.43K365.77K445.77K5.01K
Operating Income-3.53M-7.02M13.59M10.25M9.75M9.66M
Other Expenses / Income273.31K-964.70K88.34K-151.29K-99.77K-76.80K
Before Tax Income-3.85M-7.98M13.68M10.10M9.65M9.52M
Income Tax Expenses2.31M752.42K2.36M2.54M2.10M1.92M
Net Income-6.16M-8.74M11.32M7.56M7.55M7.60M
Interest Expenses156.79K162.40K101.60K123.76K129.27K164.92K
Basic Shares Outstanding3.62M3.62M3.62M3.67M3.67M21.00M
Diluted Shares Outstanding3.62M3.62M3.62M3.67M3.67M21.00M
EBITDA-3.66M-6.40M13.99M10.73M10.50M10.24M
EBITDA Margin-11.33%-15.94%29.15%34.95%31.59%35.91%
EBIT-3.69M-7.82M13.78M10.22M9.78M9.68M
EBIT Margin-11.43%-19.48%28.72%33.30%29.44%33.96%
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙